BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Capital expenditures, 2025
- $876M
- YoY, 2025
- +10.9%
- 5-year CAGR
- +18.4%
- 10-year CAGR
- +13.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $876M | +10.9% |
| 2024 | $790M | +11.1% |
| 2023 | $711M | +20.9% |
| 2022 | $588M | +6.1% |
| 2021 | $554M | +47.3% |
| 2020 | $376M | −18.4% |
| 2019 | $461M | +45.9% |
| 2018 | $316M | −0.9% |
| 2017 | $319M | −15.2% |
| 2016 | $376M | +52.2% |
| 2015 | $247M | −4.6% |
| 2014 | $259M | +5.7% |
| 2013 | $245M | +8.4% |
| 2012 | $226M | −25.7% |
| 2011 | $304M | +11.8% |
| 2010 | $272M | −12.8% |
| 2009 | $312M | −13.8% |
| 2008 | $362M | −0.3% |
| 2007 | $363M | — |